Doripenem PowerPoint PPT Presentations

Doripenem - A New Broad-Spectrum Carbapenem Antibiotic Group Member 0440213 0440216 0441515 0441523 SAR of doripenem From Penicillins To Carbapenems Carbapenem before ...

Place des Nouveaux Antibiotiques Docteur MF LUTZ Les penems :Doripenem DORIBAX Action PSDP Meilleure action anti pseudomonas par rapport l Imipenem (CMI 2-4X ...

TRATAMIENTO DE PAT GENOS MULTIRRESISTENTES Es posible la monoterapia en el tratamiento de la infecci n por Pseudomonas? Monoterapia con nuevos antibi ticos en ...

Resistance in Pseudomonas aeruginosa and Acinetobacter spp. ... Pseudomonas aeruginosa. Acinetobacter. Generally susceptible to relevant antibiotics. ...

NUEVOS ANTIMICROBIANOS Jos Manuel Guti rrez Rubio. UCI. Hospital General de Albacete. * * * * * * En ausencia de unas directrices europeas, se tienen en cuenta las ...

NUEVOS ANTIBIOTICOS JUAN VILLENA VIZCARRA HNGAI UNMSM Todos estos antibi ticos se administran por v a intravenosa en infusi n continua, aunque linezolid, debido ...

Antibiotics 101 Puja Van Epps 1/20/14 * * * * Clindamycin Inhibits protein synthesis by binding exclusively to the 50S ribosomal subunit Major uses - MRSA ...

Susceptibility Profile of KPC-Producing K. pneumoniae. Tigecycline ... Variable susceptibility to cefoxitin and cefepime. Reading Disk Diffusion & Etest ...

Title: Presentaci n de PowerPoint Author: umic9 Last modified by: akmdmin Created Date: 1/7/2004 9:25:30 AM Document presentation format: Bildschirmpr sentation

Antibiotics 102: Reading and Interpreting CLSI Antimicrobial Susceptibility Performance Documents Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases

After review of this material, the dental professional should be able to: ... Incretin Mimetic. exenatide* (BYETTA), sc pen. Synthetic GLP-1 receptor agonist ...

contact 718 467 8801 ... ANTIMICROBIAL AGENTS * * * * * * * * * * Which of the following antimicrobial agents has effective coverage for M. pneumoniae?

Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global Urinary Tract Infections Therapeutics market. The report identifies the key trends shaping and driving the global Urinary Tract Infections Therapeutics market.

Antibiotics MR. H GEE MD, FRCOG Hon. Assoc. Clinical Professor University of Warwick ...

Innovation Dilemma - the case of antimicrobials - John Turnidge The trouble with antibiotics They are designed to be harmless to the host easy to prescribe just in ...

2. 3. 4. 5. 6. Extended Spectrum Cephalosporins (3rd Gen) Extended ... Klebsiella has created a hospital, city, and state-wide hospital associated epidemic. ...

Chemistry MIP Effect on microbes - MIP Spectrum of coverage Mechanism(s) of action Mechanism(s) of resistance Pharmacology of antibiotic class mostly new info

Module 2 (of 3): Antibiotic Review* Review of selected antimicrobials By Keith Teelucksingh, PharmD Infectious Disease Pharmacist, Kaiser Permanente Vallejo

neumonia asociada a ventilacion mecanica ...

Review and Update of Antibacterial Drug Therapy Daniel Streetman, PharmD, MS Pharmacotherapy Specialist Lexicomp | Wolters Kluwer Health

Bacteria continue to out-perform clinician by developing increasing levels of resistance. Protecting the efficacy of existing antibiotic armamentarium is essential. ...

Beta-Lactam Antibiotics. Penicillins. Specific agents. Penicillin G ... Enzymes produced by bacteria which destroy beta-lactam antibiotics. Many different types ...

In compliance with continuing education requirements, all presenters must ... Kay Tomashek, MD. Jonathan Duffy, MD, EISO. Sara Schillie, MD, EISO. Alex Kallen, MD ...

Carbapenem-Resistant Enterobacteriaceae ( KPC Producing Organisms ) Arjun Srinivasan, MD Division of Healthcare Quality Promotion CDC Nothing to Disclose

Heinz Burgmann Innere Medizin I Klinische Abteilung f r Infektionen und Tropenmedizin FRAGEN Welche Keime? Wann beginne ich zu therapieren? Welche Untersuchungen?

Review of Antibiotics Part 1 Gary R. Skankey, MD, FACP, FIDSA University of Nevada School of Medicine * * * * Purpose of : To provide an overview of important ...

Title: MANAGEMENT OF THE FEBRILE NEUTROPENIC PATIENT Author: UNC Hospitals Last modified by: Powell, Amy Created Date: 3/13/2000 1:35:26 PM Document presentation format

The Centers for Disease Control and Prevention designates this educational ... CECH: The Centers for Disease Control and Prevention is a designated provider of ...

prolonged hospitalization, ICU stay, invasive devices, immunosuppression, and ... In South America, large dissemination of KPC was initially reported in K ...

ESBL-producing Enterobacteriaceae DiNubile MJ et al. Eur J Clin Microbiol Infect Dis 2005; 24: 443-9. P. aeruginosa resistance DiNubile MJ et al. Eur J Clin ...

drugs for bugs ?? antibiotics antiviralsa antifungals anti-tubercular antimalarial antihelminthic antimycobacterial antivirals antibiotics commonly known as

... and probably increasing Potential source of vancomycin resistance in staphylococci Clostridium difficile Several case ... ertapenem demonstrated a clinical ...

Anfotericina B complejo liposomal 2-10 mg/Kg/dia. Tambi n como profilaxis, nebulizada/inhalada ... absorci n irregular y toxicidad digestiva, de 200-800 mg/d a. ...

Antimicrobial Stewardship David Meyer, PharmD Clinical Pharmacy Manager Fairmont General Hospital MUE Levaquin ID in the ED * Now the common concern is often: Can ...

... and also in Klebsiella, ... deactivates carbapenem antibiotics KPC refers to Klebsiella pneumoniae carbapenemase CRE refers to carbapenem-resistant ...

Update in Clostridium difficile Martin Rodriguez University of Alabama at Birmingham No disclosures to report * In 50% of rooms the organism can be cultured from ...

Shift to European (EUCAST) breakpoints - impact on. BSAC recommendations. Derek Brown ... European Committee on Antimicrobial Susceptibility Testing ...

Nuevas dianas para la acci n de futuros antibi ticos. Nuevos Carbapenemes ... glucop ptido con una vida media extremadamente larga y potente actividad frente ...